Word: special
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...emphasized investment banking as the driver of Morgan Stanley's profits. In June, he completed the purchase of a majority stake in Salomon Smith Barney's brokerage division, instantly turning Morgan Stanley, once an élite white-shoe institution, into the largest brokerage house in America. (See TIME's special report "The Financial Crisis After One Year...
...vaccine will pose a special dilemma for everyone measuring the risks this fall. We already know there will not be enough vaccine for everyone right away. So the priority will be to vaccinate high-risk people, such as those with chronic conditions like diabetes. But high-risk people tend not to think of themselves that way. "They feel fine. They go to work and take care of their kids. They don't define themselves day to day as someone with asthma," says Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases. (Read about...
...Agriculture Commissioner Mariann Fischer Boel told the European Parliament last week there was no negotiation on the quota issue. But she promised other measures to help the farmers, including enacting special rules on state subsidies so governments can offer them a one-time aid payment...
...When U.N. special envoy Ibrahim Gambari visited Burma in 2007, one of the people he met was Kokang honcho Peng, who was trotted out to represent the junta's amity with ethnic groups. But this summer, Peng publicly rejected the idea of turning his army into a border force. By early August, the junta was accusing Peng of being behind an illegal arms-and-drugs factory. The illicit activity, claimed the regime, compelled it to invade Kokang turf, even though the warlord's business proclivities had been an open secret for years. Indeed, both the Eastern Shan...
...temporary monopoly a pharmaceutical company holds on a product that is guaranteed by its patent. With more companies able to produce a product, free-market competition drives down its price, and as its cost decreases, more people gain access to the drug. At present, unless a Harvard scientist takes special initiative to include clauses that promote global access in the license of her compound, she essentially relinquishes control over the future of her research at the time of licensing. After this point, the pharmaceutical company has free reign over the cost of the drug, and global access is rarely...